CARsgen Therapeutics Holdings Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
1.68 | 35.42 | -95.26% | -7.74 | -121.69% |
| P/S |
|
249.38 | 7.59 | 3186.56% |
|
|
| P/BV |
|
1.75 | 3.68 | -52.49% |
|
|
| P/FCF |
|
-12.49 | 55.3 | -122.58% |
|
|
| Ev/Ebitda |
|
-4.38 | 2.91 | -250.62% |
|
|
| Ev/S |
|
0 | 23.72 | -100% |
|
|
| Ev/FCF |
|
-7.47 | 63.78 | -111.71% |
|
|
| E/P |
|
-0.1289 | 0.0326 | -495.03% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -11.9 | -100% | -9154.13 | -100% |
| ROE |
|
-34.99 | 5.19 | -774.55% |
|
|
| ROA |
|
-29.79 | 3.47 | -958.67% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | -11.49 | -100% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1504 | 0.7755 | -119.39% | -0.1128 | +33.31% |
| Nеt Debt/Ebitda |
|
0 | 0.0127 | -100% |
|
|
| Debt/Ratio |
|
0.0529 | 0.1229 | -56.94% |
|
|
| Debt/Equity |
|
0.2705 | 0.802 | -66.27% |
|
|
| Debt/Net Income |
|
-0.1597 | 1.76 | -109.08% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 5.7 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0 | 0.5838 | -100% |
|
|
| Average dividend growth |
|
0 | 3.2 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 4.95 | -100% |
|
|
| Average percentage for payments |
|
0 | 23.96 | -100% |
|
|
| Difference from average difference in sector |
|
-5.7 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 28.69 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
224.47 | -40.52 | -653.97% | ||
| Growth impulse Net Income in 5 years |
|
182.04 | 94.84 | 91.94% | ||
| Growth impulse FCF in 5 years |
|
64.44 | 91.41 | -29.5% | ||
| Growth impulse EPS in 5 years |
|
2236.45 | -118.14 | -1993.05% |
IP Score
4.67/10
